Full-Time

Journey Clinical is seeking a San Diego

CA Nurse Practitioner, NP, / Physician Assistant, PA, Spravato® Clinician

Posted on 9/11/2026

Journey Clinical

Journey Clinical

51-200 employees

Ketamine-assisted psychotherapy with medical oversight

No salary listed

San Diego, CA, USA

In Person

Travel to partner therapist offices within an agreed-upon radius.

Category
Medical, Clinical & Veterinary (1)

Get referred to Journey Clinical

See people who can refer or advise you

Requirements
  • Active NP or PA license in the state of practice
  • Current, unrestricted DEA registration
  • Willingness to register/associate your DEA registration to partner site address(es) as needed for Spravato® operations
  • Comfort with outpatient monitoring and responding to clinical changes (e.g., blood pressure changes, anxiety, dissociation)
  • Strong documentation skills and reliability with protocols
  • Willingness to complete required program training (Spravato® REMS-related processes)
Responsibilities
  • Conduct psychiatric intake evaluations and screening to determine Spravato eligibility
  • Prescribe Spravato and initiate documentation for insurance prior authorization
  • Provide on-site clinical support during Spravato® dosing sessions (patients self-administer nasal spray)
  • Monitor patients during the observation period (vitals, safety checks, symptom monitoring)
  • Complete required documentation accurately and on time
  • Coordinate with Journey Clinical operations and partner sites to ensure smooth patient flow
  • Support a calm, safe environment for small cohorts (typically 3–4 patients per session block)
Desired Qualifications
  • psychiatry experience; ketamine/esketamine, TMS, infusion, or other monitoring workflows

Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.

Company Size

51-200

Company Stage

Series A

Total Funding

$11.5M

Headquarters

New York City, null

Founded

2020

Get referred to Journey Clinical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Journey Clinical updated its site on August 28, 2026 with active KAP resources.
  • The company still markets KAP for anxiety, depression, PTSD, and Spravato.
  • Partnership-driven distribution expands therapist supply without heavy clinic capex.

What critics are saying

  • Off-label ketamine anchors revenue to a single, crowded treatment niche.
  • A 2026 federal enforcement shift can squeeze psychedelic providers within months.
  • If FDA blocks broader psychedelic delivery, Journey Clinical loses its expansion thesis.

What makes Journey Clinical unique

  • Journey Clinical launched a nationwide KAP therapist directory on April 16, 2026.
  • It pairs ketamine, licensed therapists, and medical monitoring in one workflow.
  • The platform supports insurance coverage and remote dosing, lowering patient friction.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Training Programs

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

2%
The Juniper Center
Aug 4th, 2025
What is Ketamine-Assisted Psychotherapy?

For those curious to learn more, The Juniper Center has partnered with Journey Clinical - a platform that connects therapists with licensed prescribers and offers research and resources on KAP for both clients and providers.

Gateway to Solutions
Jun 21st, 2024
Ketamine-Assisted Psychotherapy (KAP) at Gateway to Solutions

Gateway to Solutions, a trusted provider of ketamine-assisted psychotherapy for eight years, has recently partnered with Journey Clinical for a seamless and collaborative KAP experience.

Crain Communications
May 1st, 2024
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model

Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.

Journey Clinical
Dec 19th, 2023
Building a Network of KAP Providers with IPI

This October, Journey Clinical launched a partnership with the Integrative Psychiatry Institute (IPI) to support their students and graduates in becoming successful Ketamine-Assisted Psychotherapy providers.

Journey Clinical
Apr 10th, 2023
SXSW Panel: The Business of Psychedelics featuring Myriam Barthes

Journey Clinical partnered up with Fluence to offer some training and then they also needed professional resource in order to grow their practice.